Production Site Inspection in Belarus Preliminary Technical Works

1. Key takeaways

Production site inspection is the most costly and uncertain item among Belarus’s preliminary technical works, but it is not triggered for every application. Whether an inspection takes place depends on the circumstances of the manufacturer and the product, and there is room for exemption; companies should treat the question of whether an inspection will occur as a stand-alone item to be confirmed before the project starts, not as something discovered in mid-course. The stakes are real: an inspection involves travel arrangements, on-site scheduling, opening of production records and, where findings arise, a corrective-action loop — all of which consume calendar time and management attention beyond the paperwork of a purely documentary review. Because the organising body’s inspection committee is drawn from the expert organisation’s own staff, the inspection’s focus mirrors the document review, which means preparation can be targeted: whatever the dossier claims about production processes, testing records and the quality system is exactly what the site will be checked against. Confirming trigger, scope and timing early converts the inspection from an ambush into a plannable work package.

2. Legal basis

3. Expert insights

Insight 1: The inspection committee is constituted by the organising body. The amended text of Resolution No. 55 retains provisions on the composition of the inspection committee, and the committee consists of staff experts of the enterprise — that is, of the expert organisation itself. The inspection is therefore carried out by the expert body’s own team, not outsourced to a third-party certification body. This has a decisive consequence: the focus of the on-site inspection and the focus of the document review form one continuum. What the dossier states about manufacturing processes, in-process controls, testing records and the quality management system is precisely what the site visit will verify. There is no separate inspectorate with a different agenda to anticipate. Preparation can thus be sharply targeted: a manufacturer that ensures the documents are truthful, current and consistent with shop-floor reality has already done most of the inspection preparation, because the reviewers on site are the same reviewers who read the file.

Insight 2: The closed list has direct significance for inspections. Since Resolution No. 211 prohibits the organising body from expanding the list of preliminary technical works, the question of whether an inspection is performed should be answerable from the list itself. When an inspection is requested, the applicant can properly ask the organising body to identify where the inspection sits in the list and what conditions trigger it. This is a materially stronger position than the pre-2026 posture of simply accepting whatever the expert body schedules. It does not mean inspections can always be resisted — where the product and its risk profile genuinely call for one, the list will support it. It means the demand must be anchored in text, and an applicant who knows the list can distinguish between a well-founded inspection and a routine reflex to inspect everything, and respond accordingly.

Insight 3: Exemption conditions are the key practical variable. Publicly available industry sources mention exemption directions including: the manufacturer’s products already being registered in Belarus, very low product risk levels, and non-sterile product categories. GRZAN treats these as a practical estimate based on industry sources, not as verified official provisions, and they must not be relied on as settled conclusions. The status of any exemption is exactly the kind of question that should be resolved in writing before the dossier is filed: ask the local representative or the organising body whether, for this specific product and manufacturer, an inspection is contemplated, and obtain the answer in writing. A written confirmation costs one round of correspondence; an unverified assumption costs an inspection the company did not plan for, with all the scheduling and travel consequences that follow.

Insight 4: Inspections spill over into the time budget. An inspection involves site scheduling, personnel travel and a corrective-action close-out, and in practice its elapsed time often exceeds that of the document review itself. Even though the total duration of preliminary technical works is bounded by 90 calendar days, the applicant’s own coordination time around an inspection — hosting, document retrieval on site, responding to findings — is not absorbed by that limit and must be reserved separately in the master plan. Companies that fold inspection preparation into their documentary review budget find the two competing for the same weeks, and both suffer. The cleaner model treats the inspection as its own work package with its own lead time, its own owners and its own contingency, sequenced so that any travel and visa requirements for the visiting committee are arranged well before the inspection window opens.

4. Practical recommendations

1. Make whether an inspection occurs the first open item at the project kick-off. Obtain written confirmation of whether it is triggered and, if so, of the inspection scope and the time window in which it will take place.
2. Run a document-to-site consistency self-check first. Since the inspection focus mirrors the document review, perform an item-by-item comparison of documents against site reality in advance, focusing on manufacturing processes, testing records and quality system documentation.
3. Reserve a separate time budget for the inspection. Do not compress inspection preparation and hosting into the document-review allocation inside the 90-day budget; give the inspection its own work package.
4. Raise any exemption claim in writing at filing. If the product appears to fall within the exemption directions, submit the claim with supporting evidence at the application stage — not when notified of an inspection.

5. Verification checklist

• □ Written confirmation obtained on whether this product triggers a production site inspection
• □ Document-to-site consistency self-check completed
• □ Separate time budget reserved for the inspection
• □ If claiming an exemption, submitted in writing at the filing stage with supporting evidence
• □ Confirmed that the inspection committee is constituted by the expert organisation and its focus matches the document review

Regulatory information verified as of 2026-10-30.

On the Eurasian Economic Union market, GRZAN’s core capabilities concentrate on three points. First, distinguishing the applicable conditions and remaining time windows of the two pathways — Union-wide registration versus national registration in each member state: the national registration procedure for medical devices in Belarus has been switched wholesale by Council of Ministers Resolution No. 211 of 2026-04-28 (state register No. 6-1/55925, effective 2026-05-01), which compressed the total time limit for preliminary technical works to 90 calendar days, closed the list of such works and prohibited the organising body from expanding it, while the window for filing applications under the national procedure treats 2027-12-31 as the critical cut-off — pathway selection must therefore be decided in step with the time window. Second, authorised representative services: GRZAN can act as the manufacturer’s statutory representative in Belarus, undertaking registration filings, responses to technical queries, registration dossier amendments and post-market reporting obligations, and has synchronised its coordination mechanisms after Council of Ministers Resolution No. 378 of 2026-07-27 (effective 2026-07-30) transferred adverse-event functions to the state organisation for pharmaceutical supervision. Third, quality system and testing support: assistance in establishing a quality management system conforming to ISO 13485, and in organising technical documentation according to the target pathway — the national pathway follows the annex to Ministry of Health Resolution No. 55, while the Union pathway follows EEC Council Decision No. 46.

For business inquiries: info@grzanglobal.com